Hematology & Oncology Doctors in Southaven, MS Accepting Medicare

4 Hematology & Oncology doctors found. Showing 1 - 4

Sohail A Minhas, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7900 Airways Blvd Ste 100, Southaven, MS 38671 Phone: 662-349-2442    Fax: 662-349-8551

Dr. Muhammad M Mirza, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7900 Airways Blvd Ste 100, Southaven, MS 38671 Phone: 662-349-2442    Fax: 662-349-0356

Sonia M Benn, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7668 Airways Blvd, Southaven, MS 38671 Phone: 662-349-9556    Fax: 901-685-9718

Dr. Syed S Azmi, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7900 Airways Blvd Ste 100, Southaven, MS 38671 Phone: 662-349-2442    Fax: 662-349-8551

News Archive

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

NAMI joins other disease advocacy organizations in support of NIH and NIMH

The National Alliance on Mental Illness (NAMI) is joining advocates from across the nation in asking President Obama to make medical research for improving health care a priority and support robust funding for the National Institutes of Health (NIH) and the National Institute of Mental Health (NIMH).

DZD researchers discover additional genetic cause for non-alcoholic fatty liver disease

In Germany about 18 million people suffer from non-alcoholic fatty liver. The causes of this disease are manifold and include environmental as well as genetic factors.

Monoclonal antibody CT-P59 shows preclinical efficacy against South African SARS-CoV-2 variant

Researchers in the Republic of Korea (South Korea), The Netherlands, and South Africa have demonstrated the potential of the monoclonal antibody CT-P59 as an effective therapeutic for coronavirus disease 2019 (COVID-19) caused by the South African B.1.351 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Read more Medical News

› Verified 9 days ago